Valuation : Seer, Inc.

Market Cap 110M 94.47M 88.58M 80.86M 152M 10.48B 153M 1.05B 410M 5.29B 412M 403M 17.54B P/E 2026 *
-1.8x
P/E 2027 * -1.94x
Enterprise Value 110M 94.47M 88.58M 80.86M 152M 10.48B 153M 1.05B 410M 5.29B 412M 403M 17.54B EV / Sales 2026 *
6.81x
EV / Sales 2027 * 5.65x
Free-Float
85.49%
Yield 2026 *
-
Yield 2027 * -
1 day-1.49%
1 week-2.46%
Current month-10.81%
1 month-7.48%
3 months+2.59%
6 months+15.12%
Current year+8.20%
1 week 1.98
Extreme 1.98
2.08
1 month 1.98
Extreme 1.98
2.25
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
2.74
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 2018-02-28
Director of Finance/CFO 58 2020-04-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 68 2024-08-12
Director/Board Member 70 2017-11-30
Director/Board Member 76 2017-11-30
Date Insider Type Main position Quantity % Market Cap.
8/18/26 Sell

Chief Financial Officer

-7,309 0.0132%
7/28/26 Free

Director

41,500 0.0750%
7/28/26 Free

Director

41,500 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
-1.49%-2.46%-2.46%-20.64% 111M
-0.63%+0.24%+9.00%+18.35% 28.2B
+0.73%+0.51%+12.63%-3.26% 7.44B
-2.83%-1.53%-7.22%+156.04% 3.55B
+1.57%+1.73%+17.25%-43.94% 2.93B
-0.17%-2.13%+51.79%+53.89% 2.18B
-4.32%-1.75%+85.88%+141.93% 1.91B
-1.82%-1.44%-2.45%+24.96% 1.77B
-0.18%+4.43%+9.94%+56.74% 1.37B
-1.95%-0.83%-38.09%-17.04% 881M
Average -1.11%-0.29%+13.63%+36.70% 5.03B
Weighted average by Cap. -0.63%+0.02%+12.42%+28.03%

Financials

2026 *2027 *
Net sales 16.1M 13.87M 13.01M 11.87M 22.37M 1.54B 22.44M 154M 60.21M 777M 60.45M 59.13M 2.58B 19.4M 16.72M 15.67M 14.31M 26.95M 1.85B 27.04M 186M 72.55M 936M 72.84M 71.25M 3.1B
Net income -61.2M -52.74M -49.45M -45.14M -85.03M -5.85B -85.3M -587M -229M -2.95B -230M -225M -9.79B -57.7M -49.72M -46.62M -42.55M -80.17M -5.51B -80.42M -553M -216M -2.78B -217M -212M -9.23B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
26-08-28 US$1.980 -1.49% 155,566
26-08-27 US$2.010 -0.50% 102,782
26-08-26 US$2.020 -0.98% 124,500
26-08-25 US$2.040 0.00% 100,637
26-08-24 US$2.040 +0.49% 207,121
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.980USD
Average target price
4.000USD
Spread / Average Target
+102.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock